trial
as of 2026-07-01Topiramate and Schizophrenia: Effects on Weight and Psychopathology
NCTId NCT02808533
at a glance
— · Active Not Recruiting
Enrollment 50 (estimated)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2026-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Active Not Recruiting
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2016-05
Primary completion
2026-08
Eligibility
ALL · 17 Years · 59 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Ontario Ministry of Health and Long Term CareCollaborator
Investigators
1
Margaret K Hahn, PhD, MDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2026-08
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
indication
indication
indication
investigator
person